Epigenomics AG EPGNF:OTCQX

RT Quote | Exchange | USD
Last | 2:05 PM EST
2.65quote price arrow up+0.06 (+2.32%)
Volume
1,525
52 week range
2.56 - 30.24

...

Loading . . .

KEY STATS

  • Open2.58
  • Day High2.65
  • Day Low2.58
  • Prev Close2.59
  • 52 Week High30.24
  • 52 Week High Date08/20/20
  • 52 Week Low2.56
  • 52 Week Low Date03/02/21
  • Market Cap16.65M
  • Shares Out5.89M
  • 10 Day Average Volume3,409.71
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-78.35

RATIOS/PROFITABILITY

  • EPS (TTM)-3.72
  • P/E (TTM)-0.71
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date03/26/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Epigenomics AG News

There is no recent news for this security.

Latest EPGNF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Epigenomics AG is a Germany-based molecular diagnostics company focused on blood-based detection, prognosis and monitoring of cancers using deoxyribonucleic acid (DNA) methylation technology. It develops and commercializes blood-based diagnostic products across multiple cancer indications. The Company's main product is Epi proColon, a blood test for colorectal cancer screening. Along with the blood-based tests the Company offers services related to research, product...
Gregory Hamilton
Chief Executive Officer
Jorge Garces Ph.D.
President
Address
Geneststrasse 5
Berlin
10829
Germany